Search Results

Filter
  • 1-10 of  178,611 results for ""INTERFERON alpha""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response.

  • Authors : Basolo A; Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, 56124, Pisa, Italy. .; Poma AM

Subjects: Adipocytes*/Adipocytes*/Adipocytes*/immunology ; Adipose Tissue*/Adipose Tissue*/Adipose Tissue*/immunology ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2022 May; Vol. 45 (5), pp. 1021-1029. Date of Electronic Publication: 2022 Feb 15.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386

Record details

×
Academic Journal

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication.

  • Authors : Li J; Insititute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Kemper T

Subjects: Hepatitis B*/Hepatitis B*/Hepatitis B*/drug therapy ; Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/drug effects ; Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/physiology

  • Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Feb 02; Vol. 12, pp. 804011. Date of Electronic Publication: 2022 Feb 02 (Print Publication: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.

  • Authors : Locke MC; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.; Fox LE

Subjects: Host-Pathogen Interactions*; Chikungunya Fever/Chikungunya Fever/Chikungunya Fever/*metabolism ; Chikungunya Fever/Chikungunya Fever/Chikungunya Fever/*virology

  • Source: Journal of virology [J Virol] 2022 Jan 12; Vol. 96 (1), pp. e0114321. Date of Electronic Publication: 2021 Oct 20.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Human N-Alpha-Acetyltransferase 60 Promotes Influenza A Virus Infection by Dampening the Interferon Alpha Signaling.

  • Authors : Ahmed F; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.; Husain M

Subjects: Acetyltransferases/Acetyltransferases/Acetyltransferases/*metabolism ; Influenza A virus/Influenza A virus/Influenza A virus/*pathogenicity ; Influenza, Human/Influenza, Human/Influenza, Human/*metabolism

  • Source: Frontiers in immunology [Front Immunol] 2022 Jan 12; Vol. 12, pp. 771792. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Interferon-α promotes MHC I antigen presentation of islet β cells through STAT1-IRF7 pathway in type 1 diabetes.

  • Authors : Jiang H; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Li Y

Subjects: Antigen Presentation* ; Diabetes Mellitus, Type 1* ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology

  • Source: Immunology [Immunology] 2022 Jun; Vol. 166 (2), pp. 210-221. Date of Electronic Publication: 2022 Mar 24.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial.

  • Authors : Huang YW; PharmaEssentia Corporation, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/adverse effects; Humans

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 May; Vol. 88 (5), pp. 2396-2407. Date of Electronic Publication: 2021 Dec 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Monocytes are the main source of STING-mediated IFN-α production.

  • Authors : Congy-Jolivet N; Laboratoire d'Immunologie, CHU de Toulouse, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.; Cenac C

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/biosynthesis ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/blood ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/immunology

  • Source: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104047. Date of Electronic Publication: 2022 May 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

APOBEC3A regulates transcription from interferon-stimulated response elements.

  • Authors : Taura M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.; Laboratory of Bioresponse Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, 565-0871 Suita, Japan.

Subjects: Cytidine Deaminase*/Cytidine Deaminase*/Cytidine Deaminase*/genetics ; Cytidine Deaminase*/Cytidine Deaminase*/Cytidine Deaminase*/metabolism ; Cytokines*/Cytokines*/Cytokines*/genetics

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 May 17; Vol. 119 (20), pp. e2011665119. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers.

  • Authors : Li H; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.; Lin X

Subjects: Hepatitis B Surface Antigens* ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use; Antigens, Surface

  • Source: Frontiers in immunology [Front Immunol] 2022 Apr 22; Vol. 13, pp. 864354. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Editorial & Opinion

Interferon-alpha-2a-Injektionen bei ausgedehnten multiplen planen Virusakanthomen als möglicher neuer Therapieansatz.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Interferon-alpha*; Humans

  • Source: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2022 Apr; Vol. 20 (4), pp. 518-519.Publisher: Blackwell Country of Publication: Germany NLM ID: 101164708 Publication Model: Print Cited Medium: Internet ISSN: 1610-0387

Record details

×
  • 1-10 of  178,611 results for ""INTERFERON alpha""